Sanofi wins EU nod for Gaucher drug Cerdelga; FDA flags counterfeit Cialis found in the mail;

@FiercePharma: Report: Livestock research lab prioritizes profits over animal health. FierceAnimalHealth article | Follow @FiercePharma

@EricPFierce: UK's MHRA expands its ban of Wockhardt's plant in Chikalthana, India to include all APIs. FiercePharmaManufacturing article | Follow @EricPFierce

@CarlyHFierce: Incoming Takeda chief ready to jump on the M&A train with reorg in place. Report | Follow @CarlyHFierce

> Sanofi ($SNY) and Genzyme were granted marketing authorization from the European Commission (EC) for Gaucher drug Cerdelga. Release (PDF)

> Counterfeit versions of Eli Lilly's ($LLY) erectile dysfunction drug Cialis were found in the mail en route to a customer in the U.S., the FDA said on Wednesday. Story

> Keryx Biopharmaceuticals ($KERX) priced an offering of 9 million shares at $12 per share, with expected proceeds of $110 million. More

> Biogen Idec ($BIIB) snagged the number one spot on a list of the world's most sustainable corporations, outranking more than 4,600 companies with a market cap over $2 billion. Article

> Pakistan's pharma industry is calling for a 15% price hike for generic and branded drugs to protect it from financial losses. Story

> The market for colorectal cancer drugs is expected to grow to $9.4 billion by 2020 despite looming patent expirations for Roche's ($RHHBY) Avastin and Merck KGaA's Erbitux, according to a new report from GBI Research. More

Medical Device News

@FierceMedDev: SV Bio changes name to Lifecode, plans rollout of NGS cancer assay. FierceDiagnostics story | Follow @FierceMedDev

@VarunSaxena2: Celator's delivery platform results in FDA's fast-track designation for its cancer candidate. FierceDrugDelivery article | Follow @VarunSaxena2

@EmilyWFierce: J&J settles the score with over 100 vaginal mesh plaintiffs. More | Follow @EmilyWFierce

> Welch Allyn buys eye exam provider, demonstrating device industry's growing interest in services. More

> China announces landmark medical device GSP rules. Report

Biotech News

@FierceBiotech: China's Innovent banks $100M to cash in on the biosimilar boom. Report | Follow @FierceBiotech

@JohnCFierce: So Martin Pule, who got his start with Brenner at Baylor on CAR-T ($CELG, $BLUE) went on the Cellectis deal ($ALCLS) is now CSO at Autolous. | Follow @JohnCFierce

@DamianFierce: @IAmBiotech weighs in on Obama's precision medicine plan. More | Follow @DamianFierce

> Kite expands its immuno-oncology brain trust in the CAR-T footrace. Article

> The CAR-T brain war: Scientific trailblazer inspires a $45M biotech startup. Story

Vaccines News

> After rocky flu season, vaccinemakers may want to follow Novartis' lead. Story

> Disneyland measles outbreak adds fuel to heated anti-vaccination debate. Item

> J&J forms consortia to accelerate Ebola vaccine development, gets €100M boost from IMI. News

> Study: GSK's malaria vaccine may not be effective when used with bed nets. More

> MSF urges GSK, Pfizer to slash pneumococcal vaccine prices. Report

Pharma Manufacturing News

> Manufacturing key to getting more effective flu jabs to market faster. Story

> Gulf Pharmaceutical commits to sterile injectable plant in Ethiopia. Report

> FDA finds more counterfeit Cialis, warns consumers. Article

> U.K. expands Wockhardt ban. More

> Biologics manufacturing helps Lonza to early turnaround. Story

And Finally… Women with Alzheimer's disease who had a prostate cancer drug added to their regimen showed stable cognition for a year, according to a new study from researchers at the University of Wisconsin-Madison. More

Suggested Articles

Look out, diabetes market: Novo Nordisk won its FDA nod for highly anticipated Rybelsus to control blood sugar in patients with Type 2 diabetes.

Insys is in fire sale mode as part of its bankruptcy plan, and now it’s been given the go-ahead to sell the opioid that helped get it there.

GSK CEO Emma Walmsley could soon have a new title: Microsoft board member. The software giant has nominated her to its board of directors.